Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18283176 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: Anti IL-12 monoclonal antibody/ABT-874;   Drug: placebo

Indicates status has not been verified in more than two years